Navigation Links
Opal Photoactivator™

ProductsOpal Photoactivator™
Company Lumenis Inc.
Item Opal Photoactivator™
  • Utilizes an advanced diode laser with consistent beam energy of 689 nanometers
  • Its modular design allows easy configuration to most diagnostic slit lamp platforms
  • Exposure time as determined by intensity, fluence, spot size, and contact lens magnification is typically only 83 seconds
  • Quality controls known as SmartLink and PowerCheck minimize the potential for inadequate drug activation
  • At-the-link power feedback, dual footswitch mode (continuous and staged), and a variable spot size of .4 to .8mm
  • Historic progress in treating AMD, pathologic myopia, and histoplasmosis
  • Only 83 seconds of low energy 689-nanometer light
  • Swift, office-based procedure
  • Only targets abnormal vessels, sparing normal vessels
  • A minimally invasive procedure
  • Received approval by FDA in April 2000
Description Until recently, most patients with age-related macular degeneration (AMD) could not expect their vision to improve or stabilize with or without treatment. Now, the Opal Photoactivator laser from Lumenis has revolutionized the standard of care and offers patients renewed hope.

Lumenis designed the Opal Photoactivator especially for use in photodynamic therapy with verteporfin, a drug produced by CIBA Vision Corporation, the eye care unit of Novartis AG. The Opal laser used in conjunction with Visudyne therapy represents an incredible advance in ocular photodynamic therapy (PDT). In this approach, the Opal laser is used not as a cutting tool but to activate a therapeutic drug in the patient's eye, providing a minimally invasive, focused treatment for AMD.

The Opal offers innovative features unavailable on any other laser -- features that ensure uncompromised treatment, safety, and patient care.

Info Lumenis Inc.
Customer Service: 877-lumenis
Web site:

Related medicine products :

1. Adson Cranial Rongeur
2. Bacon Cranial Rongeur
3. Instatrak - Cranial
4. Neuroclip Cranial Flap Fixation System
5. TEW Cranial/Spinal Retractor (A 1090)
6. De Vilbiss Cranial Rongeur
7. Stookey Cranial Rongeur
8. Marchac Cranial Rongeur
9. Cranial Drill
10. Hudson Cranial Drill
11. Tew Cranial/Spinal Retractor
Post-Surgical compression garments...
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl...
... The Albumin Cobalt Binding (ACB®) Test ... Ischemia Modified Albumin (IMA®) by measuring the ... patient serum sample. First identified in the ... albumin comes in contact with ischemic tissue ...
... test menu includes kits that quantitatively measure ... lipoprotein (a). An elevated serum or plasma ... strong and independent risk factor for cardiovascular ... 1970s have associated elevated levels of Lp(a) ...
Medicine Products:
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/22/2017)...  As the latest Obamacare repeal effort moves is ... (R-LA) and Lindsey Graham (R-SC) medical device ... industry is in an odd place.  The industry wants ... tax on medical device sales passed along with the ... increased visits and hospital customers with the funding to ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology: